Granules India Ltd - 532482 - Closure of Trading Window
Closure of Trading Window30-03-2021
These 5 stocks gained at least 15% in first quarter of last two fiscal years, do you own any?
Granules India and JB Chemicals are among the stocks that were winners in Q1 of FY20 and FY19. Here are five stocks that you can consider for studying:25-03-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting.19-03-2021
Buy Granules India: target of Rs 475: Sharekhan
Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 475 in its research report dated March 16, 2021.18-03-2021
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting15-03-2021
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting09-03-2021
Top buy and sell ideas by Sudarshan Sukhani, Mitessh Thakkar for short term
Mitessh Thakkar of mitesshthakkar.com recommends buying Bharat Electronics with a stop loss of Rs 142, target at Rs 155 and Granules India with a stop loss of Rs 336, target at Rs 353.02-03-2021
Granules India's migraine drug gets USFDA nod
Granules India Ltd's Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine tablets has been approved by the US Food and Drug24-02-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited announces approval of Acetaminophen, Aspirin and Caffeine Tablets(OTC), generic equivalent of Excedrin Migraine Tablets of GlaxoSmithKline Consumer Healthcare24-02-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting22-02-2021